Literature DB >> 16949532

Treatment of relapsed idiopathic clubfoot by complete subtalar release combined with the Ilizarov method.

Takanobu Nakase1, Natsuo Yasui, Kenji Ohzono, Nobuyuki Shimizu, Hideki Yoshikawa.   

Abstract

This study presents the clinical and radiographic outcomes of 6 feet (4 patients) with relapsed idiopathic clubfoot that were treated with a combination of subtalar release and the Ilizarov method. The mean patient age at the time of the surgery was 7.4 years (range, 4.5-10.5 years), and the mean follow-up was 5.1 years (range, 2.0-7.3 years). All cases achieved a plantigrade foot, better walking ability, and parental satisfaction with the result. Ankle joint range of motion increased from a mean of 17 degrees (range, 10-30 degrees) preoperatively to 45 degrees (range, 35-65 degrees) at final follow-up. The talocalcaneal angle improved from a mean of 26 degrees (range, 15-34 degrees) preoperatively to 55 degrees (range, 47-65 degrees) at follow-up. The mean tibiocalcaneal angle improved from 95 degrees (range, 87-115 degrees) preoperatively to 80 degrees (77-83 degrees) at follow-up, whereas the talometatarsal angle improved from a preoperative mean of -19 degrees (range, -35 to -10 degrees) to 3.5 degrees (range, -5 to 7 degrees) at follow-up. Recurrence was observed in only 1 foot with forefoot adductus, caused by a pin tract infection and early fixator removal. These cases suggest the Ilizarov method combined with subtalar release are beneficial for the treatment of relapsed idiopathic clubfoot.

Entities:  

Mesh:

Year:  2006        PMID: 16949532     DOI: 10.1053/j.jfas.2006.05.005

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  1 in total

1.  Relapsed clubfoot correction with soft-tissue release and selective application of Ilizarov technique.

Authors:  Konstantinos N Malizos; Nikolaos E Gougoulias; Zoe H Dailiana; Nikolaos Rigopoulos; Theofanis Moraitis
Journal:  Strategies Trauma Limb Reconstr       Date:  2008-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.